WO1979000853A1 - Medicine for circulatory organ - Google Patents

Medicine for circulatory organ Download PDF

Info

Publication number
WO1979000853A1
WO1979000853A1 PCT/JP1979/000065 JP7900065W WO7900853A1 WO 1979000853 A1 WO1979000853 A1 WO 1979000853A1 JP 7900065 W JP7900065 W JP 7900065W WO 7900853 A1 WO7900853 A1 WO 7900853A1
Authority
WO
WIPO (PCT)
Prior art keywords
medicine
compound
circulatory organ
spirocyclopropane
desease
Prior art date
Application number
PCT/JP1979/000065
Other languages
English (en)
French (fr)
Inventor
H Fujimura
M Hori
Original Assignee
Takeda Chemical Industries Ltd
H Fujimura
M Hori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd, H Fujimura, M Hori filed Critical Takeda Chemical Industries Ltd
Priority to DE7979900309T priority Critical patent/DE2962418D1/de
Publication of WO1979000853A1 publication Critical patent/WO1979000853A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems
PCT/JP1979/000065 1978-03-31 1979-03-13 Medicine for circulatory organ WO1979000853A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE7979900309T DE2962418D1 (en) 1978-03-31 1979-03-13 Pharmaceutical composition comprising 3-oxo-2,3-dihydro-(1)-benzothiophene-2-spirocyclopropane and this compound for use in the prophylaxis or treatment of cardiovascular disturbance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP53038383A JPS6053031B2 (ja) 1978-03-31 1978-03-31 スピロ化合物およびその製造方法
JP78/38383 1978-03-31

Publications (1)

Publication Number Publication Date
WO1979000853A1 true WO1979000853A1 (en) 1979-11-01

Family

ID=12523744

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1979/000065 WO1979000853A1 (en) 1978-03-31 1979-03-13 Medicine for circulatory organ

Country Status (6)

Country Link
US (1) US4304784A (ja)
EP (1) EP0011651B1 (ja)
JP (1) JPS6053031B2 (ja)
DE (1) DE2962418D1 (ja)
IT (1) IT1113000B (ja)
WO (1) WO1979000853A1 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646879A (en) * 1979-09-25 1981-04-28 Takeda Chem Ind Ltd Spiro compound, its preparation, and preventive and remedy for circulatory system disorder
JPS5756477A (en) * 1980-09-19 1982-04-05 Takeda Chem Ind Ltd Spiro compound, its preparation and prophylactic and remedy for circulatory disorders
JPH02144737U (ja) * 1989-05-10 1990-12-07
WO1992005780A1 (en) * 1990-10-01 1992-04-16 Brigham And Women's Hospital Beta-carotene and vitamin e therapy for inhibition of major vascular events
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7320997B2 (en) * 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
US20050009788A1 (en) * 2002-07-29 2005-01-13 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling connexin 43 expression
US7723327B2 (en) * 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
MXPA05001202A (es) * 2002-07-29 2005-11-23 Hawaii Biotech Inc Analogos carotenoides estructurales para la inhibicion y mejora de la enfermedad.
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US7763649B2 (en) * 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
EP1682196A2 (en) * 2003-11-10 2006-07-26 Angiotech International Ag Medical implants and anti-scarring agents
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
EP1750723A1 (en) * 2004-04-14 2007-02-14 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
KR100858357B1 (ko) * 2006-10-02 2008-09-11 (주) 디지탈바이오텍 벤조퓨란계 유도체 화합물을 유효성분으로 함유하는인지기능 장애의 예방 및 치료용 조성물
US8240117B1 (en) 2011-03-07 2012-08-14 Cnh America Llc Pickup helper feeding roll

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1073657A (en) 1965-03-26 1967-06-28 Pfizer Ltd Spiro-(benzodioxan-cyclopropane) derivatives
US4089970A (en) * 1977-09-07 1978-05-16 Smithkline Corporation Method of inhibiting platelet aggregation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Heterocycles. Vol. 6, No. 11 (1977) (The Sendai Institute of Hetercyclic Chemistry) Mikio Hori (A Novel Ring Contraction of 4-Bromo-2, 3-Dihydrobenzo (b) thiepin-5 (4H)-One) P1877-1880. *

Also Published As

Publication number Publication date
US4304784A (en) 1981-12-08
EP0011651A1 (en) 1980-06-11
JPS54130560A (en) 1979-10-09
JPS6053031B2 (ja) 1985-11-22
EP0011651B1 (en) 1982-04-07
EP0011651A4 (en) 1980-05-21
IT7921456A0 (it) 1979-03-30
DE2962418D1 (en) 1982-05-19
IT1113000B (it) 1986-01-20

Similar Documents

Publication Publication Date Title
WO1979000853A1 (en) Medicine for circulatory organ
AU578050B2 (en) Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
ES485540A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas, congrupos ester funcionalizados
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
IL81002A (en) 3,4-diphenyl-pyrazoline-1-carboxamide derivatives,processes for the preparation thereof and insecticidal and acaricidal compositions containing the same
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
FR2404634A1 (fr) Composes de thiazole et compositions pharmaceutiques en contenant
IL66009A (en) 2-aryl-3,4-diazabicyclo(4.n.o)alk-2-en-5-ones,their preparation and pharmaceutical compositions containing them
FR2358382A1 (fr) Nouveaux nonapeptides, leurs procedes de preparation et compositions pharmaceutiques les contenant
ES2008962A6 (es) Proceso para la preparacion de nuevos compuestos de 2-guanidinotiazol
AU584235B2 (en) New tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing them
SE8405588D0 (sv) New compounds
ES8206455A1 (es) Procedimiento para la preparacion de derivados de guanidina
ES8101624A1 (es) Un procedimiento para la preparacion de espiroketalinas con propiedades anti-inflamatorias.
AU539847B2 (en) 3,4,5-trihydroxypiperidine compounds
ES8103112A1 (es) Procedimiento para la obtencion de pseudo-trisacaridos
GB1254999A (en) Substituted nitrosalicylanilides and bactericidal and lamprecidal uses thereof
FR2453169A1 (fr) Composes de pyranone substitues en position 6 et leur utilisation comme produits pharmaceutiques
SE8803931L (sv) Nya alkoxiderivat av ginkgolider, deras framstaellning samt terapeutiska innehaallande desamma
ES478690A1 (es) Procedimiento para la preparacion de derivados de 1,1-dife- nileteno.
ES462387A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridin-azucar.
ES8203842A1 (es) Procedimiento para la obtencion de 4-aralquil-1,4-dihidro- pirdinas
JPS55105654A (en) Novel dehydropeptide compounds*their manufacture and their medical use
DK576887A (da) Farmaceutiske midler

Legal Events

Date Code Title Description
AK Designated states

Designated state(s): US

AL Designated countries for regional patents

Designated state(s): CH DE FR GB